Extra-nuclear telomerase reverse transcriptase (TERT) regulates glucose transport in skeletal muscle cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 9, 2014, Pages 1762-1769

  Shaheen, Fozia ^a   Grammatopoulos, Dimitris K ^a   Müller, Jürgen ^a   Zammit, Victor A ^a   Lehnert, Hendrik ^a,b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Ageing; Diabetes; Glucose transporter; Insulin; Muscle; TERT

Indexed keywords

DEOXYGLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 12; GLUCOSE TRANSPORTER 4; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; INSULIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL SURFACE; CELL VIABILITY; CELLULAR DISTRIBUTION; CYTOPLASM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GRANULAR CELL TUMOR; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INSULIN SENSITIVITY; MOUSE; MYOBLAST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; CANCER CELL LINE; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; INSULIN RESISTANCE; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TELOMERE SHORTENING;

AGEING; DIABETES; GLUCOSE TRANSPORTER; INSULIN; MUSCLE; TERT;

ANIMALS; BLOTTING, WESTERN; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INSULIN; MALE; MICE; MUSCLE, SKELETAL; MYOBLASTS; RNA, SMALL INTERFERING; TELOMERASE;

EID: 84904343124     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.06.018     Document Type: Article

References (37)

1. Salpea K.D., Talmud P.J., Cooper J.A., Maubaret C.G., Stephens J.W., et al. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 2010, 209:42-50.
2. Sampson M.J., Winterbone M.S., Hughes J.C., Dozio N., Hughes D.A. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care 2006, 29:283-289.
3. Monickaraj F., Aravind S., Gokulakrishnan K., Sathishkumar C., Prabu P., et al. Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol. Cell. Biochem. 2012, 365:343-350.
4. Collins K., Mitchell J.R. Telomerase in the human organism. Oncogene 2002, 21:564-579.
5. Aisner D.L., Wright W.E., Shay J.W. Telomerase regulation: not just flipping the switch. Curr. Opin. Genet. Dev. 2002, 12:80-85.
6. Uziel O., Singer J.A., Danicek V., Sahar G., Berkov E., et al. Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control. Exp. Gerontol. 2007, 42:971-978.
7. Blazer S., Khankin E., Segev Y., Ofir R., Yalon-Hacohen M., et al. High glucose induced replicative senescence: point of no return and effect of telomerase. Biochem. Biophys. Res. Commun. 2002, 296:93-101.
8. Guo N., Parry E.M., Li L.S., Kembou F., Lauder N., et al. Short telomeres compromise β-cell signaling and survival. PLoS One 2011, 6:e17858.
9. Wong J.M., Kusdra L., Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat. Cell Biol. 2002, 4:731-736.
10. Santos J.H., Meyer J.N., Skorvaga M., Annab L.A., Van Houten B. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 2004, 3:399-411.
11. Ahmed S., Passos J.F., Birket M.J., Beckmann T., Brings S., et al. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J. Cell Sci. 2008, 121:1046-1053.
12. Yang Y., Chen Y., Zhang C., Huang H., Weissman S.M. Nucleolar localization of hTERT protein is associated with telomerase function. Exp. Cell Res. 2002, 277:201-209.
13. McEachern M.J., Krauskopf A., Blackburn E.H. Telomeres and their control. Annu. Rev. Genet. 2000, 3:331-358.
14. de Lange T. Protection of mammalian telomeres. Oncogene 2002, 21:532-540.
15. Haendeler J., Dröse S., Büchner N., Jakob S., Altschmied J., et al. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler. Thromb. Vasc. Biol. 2009, 29:929-935.
16. Santos J.H., Meyer J.N., Van Houten B. Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Hum. Mol. Genet. 2006, 15:1757-1768.
17. Saretzki G. Telomerase, mitochondria and oxidative stress. Exp. Gerontol. 2009, 44:485-492.
18. Denton R.M., McCormack J.G. Fuel selection at the level of mitochondria in mammalian tissues. Proc. Nutr. Soc. 1995, 54:11-22.
19. Ponsot E., Zoll J., N'guessan B., Ribera F., Lampert E., et al. Mitochondrial tissue specificity of substrates utilisation in rat cardiac and skeletal muscles. J. Cell. Physiol. 2005, 203:479-486.
20. Kuhlow D., Florian S., von Figura G., Weimer S., Schulz N., et al. Telomerase deficiency impairs glucose metabolism and insulin secretion. Aging 2010, 2:650-658.
21. Li Y., Liu L., Tollefsbol T.O. Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J. 2010, 24:1442-1453.
22. Kimura A., Ohmichi M., Kawagoe J., Kyo S., Mabuchi S., et al. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 2004, 23:4505-4515.
23. Breitschopf K., Zeiher A.M., Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett. 2001, 493:21-25.
24. Liu J.P. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 1999, 13:2091-2104.
25. Kang S.S., Kwon T., Kwon D.Y., Do S.I. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 1999, 274:13085-13090.
26. Akiyama M., Yamada O., Hideshima T., Yanagisawa T., Yokoi K., et al. TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytes. Biochem. Biophys. Res. Commun. 2004, 316:528-532.
27. Metzinger L., Poindron P., Passaquin A.C. A rapid preparation of primary cultures of mouse skeletal muscle cells. Cytotechnology 1993, 13:55-60.
28. Nedachi T., Kanzaki M. Regulation of glucose transporters by insulin and extracellular glucose in C2C12 myotubes. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E817-E828.
29. Rogers S., Macheda M.L., Docherty S.E., Carty M.D., Henderson M.A., et al. Identification of a novel glucose transporter-like protein-GLUT-12. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E733-E738.
30. McIlrath J., Bouffler S.D., Samper E., Cuthbert A., Wojcik A., et al. Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 2001, 61:912-915.
31. Hu S.Y., Tai C.C., Li Y.H., Wu J.L. Progranulin compensates for blocked IGF-1 signaling to promote myotube hypertrophy in C2C12 myoblasts via the PI3K/Akt/mTOR pathway. FEBS Lett. 2012, 586:3485-3492.
32. Liu M., Wilk S.A., Wang A., Zhou L., Wang R.H., et al. Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR. J. Biol. Chem. 2010, 285:36387-36394.
33. Erbay E., Chen J. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J. Biol. Chem. 2001, 276:36079-36082.
34. Yoon M.S., Chen J. Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis. Mol. Biol. Cell 2013, 24:3754-3763.
35. Maher F., Davies-Hill T.M., Lysko P.G., Henneberry R.C., Simpson I.A. Expression of two glucose transporters, GLUT1 and GLUT3, in cultured cerebellar neurons: evidence for neuron-specific expression of GLUT3. Mol. Cell. Neurosci. 1991, 2:351-360.
36. Chandler J.D., Williams E.D., Slavin J.L., Best J.D., Rogers S. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 2003, 97:2035-2042.
37. Rauch C., Loughna P. C2C12 skeletal muscle cells exposure to phosphatidylcholine triggers IGF-1 like-responses. Cell. Physiol. Biochem. 2005, 15:211-224.